Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.04
0.00 (0.00%)
At close: Dec 18, 2025, 4:00 PM EST
25.13
+0.09 (0.36%)
Pre-market: Dec 19, 2025, 5:36 AM EST
Pfizer Stock Forecast
Stock Price Forecast
The 10 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $27.4, which forecasts a 9.42% increase in the stock price over the next year. The lowest target is $24 and the highest is $35.
Price Target: $27.4 (+9.42%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 2 | 2 | 1 | 0 | 0 |
| Hold | 9 | 8 | 8 | 8 | 7 | 9 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 13 | 13 | 12 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $27 | Hold | Maintains | $28 → $27 | +7.83% | Dec 17, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +11.82% | Dec 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +11.82% | Dec 12, 2025 |
| Citigroup | Citigroup | Hold Initiates $26 | Hold | Initiates | $26 | +3.83% | Dec 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +39.78% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
63.12B
from 63.63B
Decreased by -0.79%
Revenue Next Year
62.36B
from 63.12B
Decreased by -1.21%
EPS This Year
3.17
from 1.41
Increased by 124.71%
EPS Next Year
3.12
from 3.17
Decreased by -1.72%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 67.2B | 66.3B | ||||
| Avg | 63.1B | 62.4B | ||||
| Low | 59.8B | 58.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.5% | 5.0% | ||||
| Avg | -0.8% | -1.2% | ||||
| Low | -6.0% | -7.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.50 | 3.47 | ||||
| Avg | 3.17 | 3.12 | ||||
| Low | 2.94 | 2.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 147.6% | 9.2% | ||||
| Avg | 124.7% | -1.7% | ||||
| Low | 108.2% | -15.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.